Get public-private partnerships right for target-oriented growth
Mint Bangalore|January 06, 2025
The UK's new government should engage the private sector with deals that achieve public objectives
MARIANA MAZZUCATO

The UK's Labour government has given serious thought to the public investment needed to get the economy back on track after 14 years of austerity, neglect of social infrastructure and capital flight triggered by Brexit and economic uncertainty. The situation demands a new strategy to tackle big problems like child poverty, health inequities, a weak industrial base and struggling public infrastructure.

What should this look like? The UK department for business and trade's 'green paper' titled 'Invest 2035' is a promising start. In my own response during the public consultation period, I stressed that an industrial strategy should be oriented around key missions like achieving net-zero emissions, rather than specific sectors, as London appears to be doing; while it has set itself five 'missions,' they seem more like goals with some targets, rather than being central to the way government and industry work together.

For Labour to deliver on its agenda, it must get its public-private partnerships (PPPs) right. Past collaborations in the UK had the state overpaying and private sector under-delivering. After the Brexit referendum, for example, the government gave Nissan £61 million to make cars in the UK. But Nissan still abandoned a planned expansion at its Sunderland plant and the promised jobs never materialized.

Bu hikaye Mint Bangalore dergisinin January 06, 2025 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

Bu hikaye Mint Bangalore dergisinin January 06, 2025 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MINT BANGALORE DERGISINDEN DAHA FAZLA HIKAYETümünü görüntüle
Mint Bangalore

Nvidia Shows New Chips, Inks Toyota Deal for Robotic Cars

Shares of Toyota, Nvidia's suppliers rise on optimism about the AI chip maker's prospects

time-read
3 dak  |
January 08, 2025
Mint Bangalore

DIAL drops plea over Hindon ops expansion

Delhi International Airport Ltd (DIAL) on Tuesday withdrew its legal challenge against the Centre's decision to allow the Airports Authority of India (AAI) to operate scheduled commercial flights from the Indian Air Force Station in Hindon, Ghaziabad.

time-read
1 min  |
January 08, 2025
Mint Bangalore

Auto sales rise 9% in 2024 despite headwinds: Fada

Inventory build-up, delayed harvest payments, weak consumer sentiment weighed on demand in Dec

time-read
1 min  |
January 08, 2025
Mint Bangalore

Razorpay Charts Return to India; Eyes Expansion, IPO

Firm is likely to complete its reverse-flip in six months, with an IPO expected in two years

time-read
3 dak  |
January 08, 2025
Mint Bangalore

Bank profits set to moderate in FY26 as bad assets rise

Ind-Ra sharply revised down its FY25 system credit growth estimate to 13-13.5% from 15% earlier

time-read
2 dak  |
January 08, 2025
Mint Bangalore

Lloyds Metals shines on likely gains from acquisition, capex

Lloyds Metals & Energy Ltd's shares have gained about 15% so far in 2025 after the company's quarterly update and announcement of employee stock options (Esops) for its 6,000 workers.

time-read
1 min  |
January 08, 2025
Mint Bangalore

Another tough year for FMCG?

Feeling blue

time-read
2 dak  |
January 08, 2025
Mint Bangalore

Your fancy, new ETF might be a little too fancy

Exchange-traded funds have mostly been great investments, but they are getting too complex for their own good

time-read
4 dak  |
January 08, 2025
Mint Bangalore

Risks to economy escalating in 2025, cautions SBICAPS

Rising household debt, fluctuating FII flows among risks that threaten to amplify economic fragility: Report

time-read
1 min  |
January 08, 2025
Mint Bangalore

Intas Pharma bags another overseas company

Gujarat-based drug-maker Intas Pharmaceuticals Ltd., which counts private equity firm ChrysCapital, Singapore state investment firm Temasek, and Abu Dhabi Investment Authority (ADIA) as its investors, has signed a deal to acquire a biologic medication brand from US-based Coherus Biosciences.

time-read
1 min  |
January 08, 2025